tradit
vaccin
virus
design
target
surfac
protein
ie
antigen
trigger
immun
system
produc
specif
antibodi
captur
neutral
virus
howev
virus
often
evolv
quickli
antigen
prone
mutat
avoid
recognit
antibodi
antigen
drift
limit
antibodymedi
immun
could
address
tcell
mediat
immun
abl
recogn
conserv
viral
hla
peptid
present
virusinfect
cell
thu
target
conserv
region
genom
viru
tcell
epitopebas
vaccin
less
subject
mutat
may
work
effect
differ
strain
viru
propos
person
workflow
identifi
optim
set
tcell
epitop
base
hla
allel
immunopeptidom
individu
person
specif
workflow
train
machin
learn
model
immunopeptidom
predict
hla
peptid
conserv
region
viru
like
trigger
respons
person
cell
appli
workflow
identifi
tcell
epitop
viru
caus
recent
pandem
countri
across
globe
sinc
loui
pasteur
experi
live
attenu
cholera
vaccin
inactiv
anthrax
vaccin
end
centuri
method
produc
vaccin
save
billion
live
still
use
today
vaccin
design
stimul
host
immun
system
elicit
specif
antibodi
bind
correspond
antigen
surfac
viru
neutral
viru
addit
memori
b
cell
form
provid
longterm
protect
rememb
antigen
quickli
produc
antibodi
futur
reexposur
viru
howev
antibodi
memori
b
cell
specif
antigen
later
prone
mutat
avoid
recognit
former
call
antigen
drift
mutat
viru
escap
antibodi
infect
host
cell
depend
tcell
mediat
immun
fight
viru
insid
infect
cell
viral
protein
process
short
peptid
load
onto
mhc
protein
mhc
major
histocompat
complex
subsequ
mhcpeptid
complex
present
surfac
infect
cell
recognit
specif
cell
activ
cell
recogn
clear
infect
cell
similar
antigenantibodi
associ
tcell
immun
also
depend
strictli
mhcpeptid
complex
mhc
protein
encod
human
leukocyt
antigen
hla
gene
complex
locat
among
genet
variabl
region
human
genom
hla
allel
essenti
chang
one
individu
anoth
allel
present
certain
set
peptid
hla
peptid
present
surfac
infect
cell
recogn
cell
call
tcell
epitop
last
least
vaccin
provid
longterm
robust
protect
essenti
identifi
tcell
epitop
origin
conserv
region
viru
given
extrem
high
specif
mhcpeptidet
cell
mechan
person
approach
desir
precis
identifi
optim
conserv
tcell
epitop
individu
person
march
spread
countri
contin
within
three
month
sinc
decemb
number
infect
case
soar
number
death
surpass
worldwid
epidem
initi
start
china
major
infect
case
massiv
cluster
thousand
case
broken
sever
countri
includ
itali
iran
south
korea
franc
spain
germani
unit
state
outbreak
also
crippl
global
economi
caus
worst
chao
market
rout
sinc
financi
crisi
potent
vaccin
solut
pandem
tradit
vaccin
design
may
limit
appli
less
fatal
rate
number
infect
case
three
month
exceed
time
total
number
sar
mer
two
virus
corona
famili
caus
recent
outbreak
high
level
contagi
may
suggest
abl
mutat
quickli
adapt
probabl
even
influenza
thu
vaccin
base
antibodi
memori
b
cell
may
becom
obsolet
soon
introduc
instanc
case
influenza
inocul
peopl
updat
vaccin
everi
year
often
partial
effect
tradit
univers
vaccin
may
also
caus
autoimmun
diseas
multipl
sclerosi
type
diabet
system
lupu
tcell
epitopebas
vaccin
explor
recent
year
thank
capabl
target
conserv
epitop
henc
provid
longterm
protect
differ
strain
virus
use
epitop
vaccin
ingredi
also
safeti
advantag
use
attenu
inactiv
virus
tcell
epitopebas
vaccin
develop
malaria
hiv
hepat
c
viru
influenza
tuberculosi
bcg
variou
success
rate
bcg
induc
tcell
respons
larg
number
antigen
diseas
vaccin
depend
select
epitop
recent
studi
influenza
auladel
et
al
suggest
cell
respons
emerg
role
influenza
protect
knowledg
neoantigen
use
cancer
immunotherapi
vaccin
prior
work
tcell
viru
vaccin
involv
peptid
pathogen
protein
neoantigen
actual
present
hla
class
complex
subtyp
determin
mass
spectrometri
neoantigen
univers
hla
type
necessarili
obtain
directli
pathogen
protein
could
cisand
transsplic
peptid
noncod
region
thu
propos
person
workflow
use
mass
spectrometri
togeth
recent
deep
learn
model
directli
identifi
conserv
tcell
epitop
surfac
virusinfect
cell
workflow
combin
cancer
immunotherapi
platform
part
detail
step
workflow
explain
follow
sick
cell
obtain
patient
blood
sampl
genom
sequenc
give
hla
type
well
tcr
sequenc
immunopeptidom
obtain
mass
spectrometri
analyz
peak
x
databas
search
use
noenzym
option
immunopeptidom
use
retrain
deepnovo
hla
subtyp
left
person
deepnovo
model
use
analyz
mass
spectrometri
data
find
peptid
miss
peak
x
databas
search
cisor
transsplic
peptid
hla
type
person
approach
enabl
comprehens
accur
identif
neoantigen
effect
neoantigen
select
hla
allel
previou
research
sarscov
suggest
spike
protein
main
antigen
compon
respons
induc
host
immun
respons
thu
import
target
vaccin
antivir
develop
promis
result
vaccin
develop
base
full
sequenc
protein
report
mous
model
without
mass
spectrometri
data
use
comput
part
workflow
figur
identifi
potenti
target
peptid
develop
epitopebas
vaccin
tabl
report
optim
tcell
epitop
top
frequent
hla
class
allel
chines
popul
follow
use
netctlpan
server
find
potent
target
peptid
protein
genbank
netctlpan
tool
integr
peptid
mhc
bind
predict
proteasom
c
termin
cleavag
tap
transport
effici
combin
rank
score
given
pair
peptid
hla
allel
score
repres
rank
predict
score
set
random
natur
peptid
filter
netctlpanpredict
peptid
rank
score
threshold
filter
peptid
remain
averag
allel
candid
peptid
align
peptid
uniprot
human
databas
show
none
selfpeptid
next
appli
iedb
immunogen
predict
tool
predict
immunogen
peptid
median
immunogen
score
use
threshold
select
top
peptid
tabl
show
top
candid
correspond
predict
immunogen
score
includ
allel
candid
peptid
rank
mhc
score
predict
netctlpan
see
result
uniqu
peptid
among
candid
peptid
report
top
frequent
allel
show
differ
hla
allel
prefer
differ
viral
peptid
differ
bind
affin
fact
three
implic
epitopebas
vaccin
design
specif
individu
person
accord
hisher
hla
allel
person
respons
viru
infect
might
correl
hisher
hla
allel
fact
divers
part
natur
select
speci
surviv
hypothesi
may
consequ
treatment
patient
prevent
gener
optim
cell
may
therapeut
consequ
earli
rapid
respons
highli
effici
cell
could
help
control
viru
multipl
henc
prevent
cytokin
storm
lung
similar
analysi
perform
nucleocapsid
protein
result
report
tabl
hla
class
three
loci
common
allel
b
common
allel
c
common
allel
thu
total
common
allel
propos
extend
tabl
allel
common
allel
predict
tcell
epitop
verifi
mass
spectrometri
immun
respons
assay
figur
give
two
method
appli
vaccin
modulo
method
select
proper
adjuv
dendrit
cell
design
epitopebas
vaccin
person
first
identifi
hla
allel
base
alleleepitop
associ
assembl
hlaspecif
vaccin
depict
figur
given
current
limit
data
genom
viru
candid
peptid
predict
sole
hla
allel
immunopeptidom
data
avail
train
person
deep
learn
model
immunopeptidom
individu
person
improv
epitop
predict
